National and Kapodistrian University of Athens
Αλληλούχηση επόμενης γενιάς (next generation sequencing) ως εργαστηριακό διαγνωστικό εργαλείο σε σπάνια γενετικά νοσήματα και αξιολόγηση των ευρημάτων με βιοπληροφορικές και εργαστηριακές μεθόδους
Abstract
dc:descriptionAbout 6000 to 7000 different rare disorders with suspected genetic etiologies have been described and almost 4500 causative gene(s) have been identified. The advent of next-generation sequencing (NGS) technologies has revolutionized genomic research and diagnostics, representing a major advance in the identification of pathogenic genetic variations. This thesis presents the application of NGS as laboratory diagnostic tool in rare genetic disorders, where 500 patients were referred for genetic analysis of disorders with unknown, but likely genetic, etiology. A phenotype-driven proband-only exome sequencing (ES) strategy was applied for the investigation of rare disorders, in the context of optimizing ES diagnostic yield and minimizing costs and time to definitive diagnosis. Overall molecular diagnostic yield reached 50% in the proband cohort and characterized 279 pathogenic variants in 248 cases, 125 of which were novel and 154 known contributing information to the international community of disease and variant databases. Additionally, in this study a consanguineous family from Afghanistan is presented, with a novel homozygous synonymous pathogenic variant c.783G>A, p. (Ala261Ala) in the ARPC1B gene that causes a similar syndrome but no thrombocytopenia. Recently, a novel syndrome of combined immune deficiency, infections, allergy, and inflammation has been attributed to mutations in the gene encoding actin-related protein 2/3 complex subunit 1B (ARPC1B), which is a key molecule driving the dynamics of the cytoskeleton. Homozygous mutations in the ARPC1B gene have been found to result in the disruption of the protein structure and cause an autosomal recessive syndrome of combined immune deficiency, impaired T-cell migration and proliferation, increased levels of immunoglobulin E (IgE) and immunoglobulin A (IgA), and thrombocytopenia. To date, only a few individuals have been diagnosed with the ARPC1B deficiency syndrome worldwide. Targeted RNA studies in members of the family in our study demonstrated that the variant affects the normal splicing process of mRNA, resulting in a marked reduction of the levels of primary (normal) RNA transcript of the ARPC1B gene in the affected patients and likely premature termination from the abnormally spliced mRNA. Overall, this study demonstrates that ES provides an opportunity to resolve the genetic etiology of many patients and disorders, supporting appropriate medical management and genetic counseling. In cases with complex phenotypes, the identification of complex genotypes may contribute to more comprehensive clinical management. In the context of effective multidisciplinary collaboration between clinicians and laboratories, ES provides an efficient and appropriate tool for first-tier genomic analysis.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Marinakis, Nikolaos
- Μαρινάκης, Νικόλαος
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51465